Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
The Use of Emetine for the Treatment of SARS-CoV-2 Infection
Case ID:
TAB-3597
Web Published:
12/6/2022
This technology includes the clinical use of the small compound emetine for the treatment of SARS-CoV-2. Previous work has shown that emetine has antiviral properties against some DNA and RNA viruses. It is thought that the mechanism may involve blocking protein synthesis. Work has shown that emetine has potential antiviral activity in multiple tissues that may make it suitable for the treatment of COVID-19.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/The_Use_of_Emetine_for_the_T reatment_of_SARS-CoV-2_Infection
Keywords:
Emetine
Infection
SARS-CoV-2
treatment
VLXXXX
WIXXXX
WKXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Ami Gadhia
Senior Technology and Patent Specialist
NIH Technology Transfer
301-827-7159
ami.gadhia@nih.gov